Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats

Pharmacological Research

Volumn 56, Issue 2, 2007, Pages 175-183

  Ringseis, Robert ^a   Pösel, Stefanie ^a   Hirche, Frank ^a   Eder, Klaus ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Carnitine; Liver; OCTN2; PPAR ; Rat; Small intestine

Indexed keywords

CARNITINE; CLOFIBRATE; LYSINE DERIVATIVE; MESSENGER RNA; ORGANIC CATION TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TRIMETHYLLYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN; CONTROLLED STUDY; DRUG EFFECT; INTESTINE; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ACYL-COA OXIDASE; ALDEHYDE-LYASES; ALKANE 1-MONOOXYGENASE; ANIMALS; ANTILIPEMIC AGENTS; BETAINE; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; CLOFIBRATE; GAMMA-BUTYROBETAINE DIOXYGENASE; INTESTINE, SMALL; LIVER; LYSINE; MALE; MUSCLE, SKELETAL; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 34548126519     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.06.001     Document Type: Article

References (60)

1. Steiber A., Kerner J., and Hoppel C.L. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25 (2004) 455-473
2. Rebouche C.J., and Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18 (1998) 39-61
3. Lohninger A., Pittner G., and Pittner F. L-carnitine: new aspects of a known compound-a brief survey. Chem Monthly 136 (2005) 1255-1268 10.1007/s00706-005-0339-2
4. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyl-transferase system. From concept to molecular analysis. Eur J Biochem 244 (1997) 1-14
5. Paul H.S., and Adibi S.A. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J Clin Invest 64 (1979) 405-412
6. Bhuiyan A.K., Bartlett K., Sherratt H.S., and Agius L. Effects of ciprofibrate and 2-[5-(4-chlorphenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Biochem J 253 (1988) 337-343
7. Paul H.S., Gleditsch C.E., and Adibi S.A. Mechanism of increased hepatic concentration of carnitine by clofibrate. Am J Physiol 251 (1986) E311-E315
8. Luci S., Geissler S., König B., Koch A., Stangl G.I., Hirche F., et al. PPARα agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 350 (2006) 704-708
9. Sekine T., Kusuhara H., Utsunomiya-Tate N., Tsuda M., Sugiyama Y., Kanai Y., et al. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem Biophys Res Commun 251 (1998) 586-591
10. Tamai I., Ohashi R., Nezu J.I., Yabuuchi H., Oku A., Shimane M., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273 (1998) 20378-20382
11. Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466 (2000) 315-327
12. Lamhonwah A.M., and Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345 (2006) 1315-1325
13. Costet P., Legendre C., More J., Edgar A., Galtier P., and Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273 (1998) 29577-29585
14. Mandard S., Muller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61 (2004) 393-416
15. van Vlies N., Wanders R.J.A., and Vaz F.M. Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal Biochem 354 (2006) 132-139
16. Bremer J. Carnitine-metabolism and functions. Physiol Rev 63 (1983) 1420-1480
17. Slitt A.L., Cherrington N.J., Hartley D.P., Leazer T.M., and Klaassen C.D. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30 (2002) 212-219
18. Alnouti Y., Petrick J.S., and Klaassen C.D. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34 (2006) 477-482
19. Rebouche C.J. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N.Y. Acad Sci 1033 (2004) 30-41
20. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70 (2006) 829-837
21. Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21 (1999) 91-94
22. Yokogawa K., Higashi Y., Tamai I., Nomura M., Hashimoto N., Nikaido H., et al. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice. J Pharmacol Exp Ther 289 (1999) 224-230
23. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
24. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137 (1996) 354-366
25. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U.S.A 91 (1994) 7355-7359
26. Shimakura J., Terada T., Saito H., Katsura T., and Inui K.I. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor α. Am J Physiol 291 (2006) G851-G856
27. Newaz M.A., Ranganna K., and Oyekan A.O. Relationship between PPARα activation and NO on proximal tubular Na+ transport in the rat. BMC Pharmacol 4 (2004) 1
28. Vaz F.M., and Wanders R.J. Carnitine biosynthesis in mammals. Biochem J 361 (2002) 417-429
29. Tanphaichitr V., and Broquist H.P. Site of carnitine biosynthesis in the rat. J Nutr 104 (1974) 1669-1673
30. Bohmer T. Conversion of butyrobetaine to carnitine in the rat in vivo. Biochim Biophys Acta 343 (1974) 551-557
31. Nagai K., Takikawa O., Kawakami N., Fukao M., Soma T., Oda A., et al. Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2. Arch Biochem Biophys 452 (2006) 29-37
32. Brown N.F., Ill J.K., Esser V., Kickland J.L., Corkey B.E., Foster D.W., et al. Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation. Inter-tissue and inter-species expression of CPT I and CPT II enzymes. Biochem J 327 (1997) 225-231
33. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244 (1997) 1-14
34. Esser V., Brown N.F., Cowan A.T., Foster D.W., and Mc Garry J.D. Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase 1 (M-CPT1): M-CPT1 is the predominant CPT1 isoform expressed in both white (epididymal) and brown adipocytes. J Biol Chem 271 (1996) 6972-6977
35. National Research Council. Guide for the Care and Use of Laboratory Animals. Publication no. 85-23 (rev.). National Institutes of Health, Washington, DC; 1985.
36. Reeves P.G., Nielsen F.H., and Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
37. Vernez L., Wenk M., and Krähenbühl S. Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 18 (2004) 1233-1238
38. - Δ Δ CT method. Methods 25 (2001) 402-408
39. Ringseis R., Muschick A., and Eder K. Dietary oxidized fat prevents ethanol-induced triacylglycerol accumulation and increases expression of PPARα target genes in rat liver. J Nutr 137 (2007) 77-83
40. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275 (2000) 40064-40072
41. Paul H.S., Sekas G., and Adibi S.A. Carnitine biosynthesis in hepatic peroxisomes. Demonstration of gamma-butyrobetaine hydroxylase activity. Eur J Biochem 203 (1992) 599-605
42. Gloerich J., van Vlies N., Jansen G.A., Denis S., Ruiter J.P., van Werkhoven M.A., et al. A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARα-dependent and -independent pathways. J Lipid Res 46 (2005) 716-726
43. Rebouche C.J. Effect of dietary carnitine isomers and gamma-butyrobetaine on L-carnitine biosynthesis and metabolism in the rat. J Nutr 113 (1983) 1906-1913
44. Berardi S., Stieger B., Wachter S., O'Neill B., and Krahenbühl S. Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesicles. Hepatology 28 (1998) 521-525
45. Higashi Y., Yokogawa K., Takeuchi N., Tamai I., Nomura M., Hashimoto N., et al. Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice. J Pharm Pharmacol 53 (2001) 527-533
46. Hoppel C.L., and Davis A.T. Inter-tissue relationships in the synthesis and distribution of carnitine. Biochem Soc Trans 14 (1986) 673-674
47. Zaspel B.J., Sheridan K.J., and Henderson L.M. Transport and metabolism of carnitine precursors in various organs of the rat. Biochim Biophys Acta 631 (1980) 192-202
48. Davis A.L., and Hoppel C.L. Effect of starvation on the disposition of free and peptide-linked trimethyllysine in the rat. J Nutr 116 (1986) 760-767
49. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103 (1999) 1489-1498
50. Lahjouji K., Maol C., Mitchell G.A., and Qureshi I.A. L-carnitine transport in mouse renal and intestinal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 1558 (2002) 82-93
51. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290 (1999) 1482-1492
52. Nemali M.R., Usuda N., Reddy M.K., Oyasu K., Hashimoto T., Osumi T., et al. Comparison of constitutive and inducible levels of expression of peroxisomal β-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 48 (1988) 5316-5324
53. Cook W.S., Yeldandi A.V., Rao M.S., Hashimoto T., and Reddy J.K. Less extrahepatic induction of fatty acid β-oxidation enzymes by PPARα. Biochem Biophys Res Commun 278 (2000) 250-257
54. Cullingford T.E., Dolphin C.T., and Sato H. The peroxisome proliferator-activated receptor α-selective activator ciprofibrate upregulates expression of genes encoding enzymes in rat brain. Neuropharmacology 42 (2002) 724-730
55. De Souza A.T., Cornwell P.D., Dai X., Caguyong M.J., and Ulrich RG. Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscle. Toxicol Sci 92 (2006) 578-586
56. Sharma R.K., Lake B.G., Makowski R., Bradshaw T., Earnshaw D., Dale J.W., et al. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. Eur J Biochem 184 (1989) 69-78
57. van Bilsen M., van der Vusse G.J., Gilde A.J., Lindhout M., and van der Lee K.A. Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression. Mol Cell Biochem 239 (2002) 131-138
58. Zoete V, Grosdidier A, Michielin O. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim Biophys Acta [Epub ahead of print].
59. Surapureddi S., Viswakarma N., Yu S., Guo D., Rao M.S., and Reddy J.K. PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. Biochem Biophys Res Commun 343 (2006) 535-543
60. Zhu Y., Kan L., Qi C., Kanwar Y.S., Yeldandi A.V., Rao M.S., et al. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem 275 (2000) 13510-13516